Qu et al. have shown that in patients with cerebral infarction, the ADAMTS13 administration resulted in reduced expression of inflammatory molecules such as intercellular cell adhesion molecule-1 and matrix metalloproteinase-9, suggesting the endothelial- and neuroprotective role of ADAMTS13 [35]. This evidence concerns the gene MMP9 and cerebral infarction.